To me the central point is share price. I'd like to get my money back and there are only two ways for that to happen: sell (for a profit) and dividends. I'm too old to wait for this to ever pay dividends (LOL), which leaves selling at a profit, which means increasing the share price.
Share price is a function of expenses and revenue, and LQMT has cut expenses about as much as possible, which leave revenue. As far as I can tell, there are three possible revenue streams: (a) manufacturing; (b) selling new licenses; and (c) royalties from licensees (i.e., Eontec).
We know that LQMT isn't going to do any manufacturing unless they do another strategic review some time in the future.
IMO, Li isn't going to start selling licenses to LQMT technology. Doing so could decrease revenue streams to the "maze."
So, IMO, it all boils down to royalties from Eontec, and therein lies the rub. How does LQMT collect royalties from Eontec when Li is the CEO of both companies and a substantial shareholder in both? To those who say that Li has 400 million reasons to divert revenue to LQMT, Li may have reasons that we have not yet hypothesized upon for not doing so.
IMO, the issue with any product manufactured by the maze is two fold: (1) does the product infringe a LQMT patent such that LQMT's consent is necessary for its importation into the US; and (2) will Li give such consent at a meaningful amount.
Until Li addresses his conflicts of interests and makes certain that negotiations are handled at arms length, there is nothing (other than his fiduciary duty to LQMT and Eontec shareholders) to prevent Li from negotiating with himself a royalty of 1/10 of 1 cent per nail imported into the US. Would such a revenue stream have a meaningful impact on LQMT share price, I doubt it.
News 
Market Data 
Discover 
AI
